nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Beyond Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia
|
Hillmen, Peter |
|
2006 |
33 |
S5 |
p. 23-28 6 p. |
artikel |
2 |
Contents
|
|
|
2006 |
33 |
S5 |
p. A1- 1 p. |
artikel |
3 |
Introduction
|
Cheson, Bruce D. |
|
2006 |
33 |
S5 |
p. 1- 1 p. |
artikel |
4 |
Masthead
|
|
|
2006 |
33 |
S5 |
p. CO2- 1 p. |
artikel |
5 |
Monoclonal Antibody Therapy for B-Cell Malignancies
|
Cheson, Bruce D. |
|
2006 |
33 |
S5 |
p. 2-14 13 p. |
artikel |
6 |
Novel Therapeutic Strategies With Alemtuzumab for Chronic Lymphocytic Leukemia
|
Rai, Kanti R. |
|
2006 |
33 |
S5 |
p. 15-22 8 p. |
artikel |
7 |
Strategies in the Management of Alemtuzumab-Related Side Effects
|
Österborg, Anders |
|
2006 |
33 |
S5 |
p. 29-35 7 p. |
artikel |
8 |
The Role of Alemtuzumab in Nonmyeloablative Hematopoietic Transplantation
|
Giralt, Sergio |
|
2006 |
33 |
S5 |
p. 36-43 8 p. |
artikel |
9 |
The Role of Alemtuzumab in the Management of T-Cell Malignancies
|
Dearden, Claire |
|
2006 |
33 |
S5 |
p. 44-52 9 p. |
artikel |